Fund Holdings — Artia Global Partners LP

Total Portfolio Value:
$491.79M
Total Bought:
$71.30M
Total Sold:
$82.52M
Net Transaction:
-$11.22M
Notable People:
Onusa Nmn Chantanapongwanij, Artia Global Partners Gp Llc
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Insmed Incorporated(INSM)589,052589,0520$62.80M$67.23M13.67%+$4.43M
Revolution Medicines, Inc.(RVMD)185,390185,3900$34.72M$38.05M7.74%+$3.33M
ABIVAX Société AnonymeADS(ABVX)516,447364,268-152,179$68.82M$36.07M7.33%-$32.75M
BrightSpring Health Services, Inc.(BTSG)517,315609,944+92,629$36.08M$34.61M7.04%-$1.46M
Trevi Therapeutics, Inc.(TRVI)2,210,8522,210,8520$41.23M$31.66M6.44%-$9.57M
argenx SEADR(ARGX)29,73929,7390$27.59M$28.52M5.80%+$926.1K
Travere Therapeutics, Inc.(TVTX)339,033398,493+59,460$19.26M$23.46M4.77%+$4.20M
Alkermes plcSHS(ALKS)448,964448,9640$23.52M$18.19M3.70%-$5.33M
Guardant Health, Inc.(GH)38,10096,704+58,604$5.72M$17.25M3.51%+$11.53M
AstraZeneca PLC(AZN)98,37698,3760$18.65M$15.88M3.23%-$2.77M
Quest Diagnostics Incorporated(DGX)65,12265,1220$13.80M$15.18M3.09%+$1.38M
Dianthus Therapeutics, Inc.(DNTH)162,990165,735+2,745$15.89M$14.59M2.97%-$1.30M
Revvity, Inc.(RVTY)080,948+80,948$0$12.38M2.52%+$12.38M
Newamsterdam Pharma Company
ORDINARY SHARES
503,936503,9360$17.08M$12.26M2.49%-$4.82M
Merck & Co., Inc.(MRK)46,70080,500+33,800$6.00M$11.70M2.38%+$5.70M
Johnson & Johnson(JNJ)22,60027,100+4,500$5.74M$7.17M1.46%+$1.43M
Bruker Corporation(BRKR)0103,796+103,796$0$6.72M1.37%+$6.72M
Biogen Inc.(BIIB)18,43729,237+10,800$3.98M$6.60M1.34%+$2.62M
Edgewise Therapeutics, Inc.(EWTX)98,800161,175+62,375$4.01M$6.54M1.33%+$2.53M
Viking Therapeutics, Inc.(VKTX)180,731180,7310$7.05M$5.89M1.20%-$1.16M
Rapport Therapeutics, Inc.(RAPP)138,508166,508+28,000$5.77M$5.59M1.14%-$177.0K
Thermo Fisher Scientific Inc.(TMO)07,610+7,610$0$5.14M1.04%+$5.14M
Absci Corporation464,444464,4440$5.38M$5.00M1.02%-$380.8K
Roivant Sciences Ltd.SHS(ROIV)129,800129,8000$4.59M$4.75M0.97%+$153.2K
Cytokinetics, Incorporated(CYTK)70,70070,7000$6.02M$4.66M0.95%-$1.36M
Scholar Rock Holding Corporation(SRRK)96,28596,2850$5.30M$4.65M0.95%-$643.2K
Belite Bio, IncADS(BLTE)24,98924,9890$3.85M$4.24M0.86%+$395.7K
10x Genomics, Inc.CL A(TXG)046,300+46,300$0$4.18M0.85%+$4.18M
Ascendis Pharma A/S(ASND)17,74017,7400$4.73M$4.04M0.82%-$689.9K
Celcuity Inc.(CELC)59,31650,522-8,794$6.21M$4.02M0.82%-$2.19M
GRAIL, Inc.(GRAL)025,200+25,200$0$3.53M0.72%+$3.53M
Mineralys Therapeutics, Inc.(MLYS)137,800137,8000$3.72M$3.46M0.70%-$254.9K
Enliven Therapeutics Inc72,10072,1000$3.66M$3.31M0.67%-$354.0K
Protagonist Therapeutics Inc22,95122,9510$2.81M$3.23M0.66%+$420.2K
Twist Bioscience Corporation(TWST)015,300+15,300$0$2.96M0.60%+$2.96M
Oruka Therapeutics, Inc.(ORKA)33,40033,4000$3.18M$2.78M0.57%-$396.8K
United Therapeutics Corporation(UTHR)5,0005,0000$2.71M$2.71M0.55%+$300
Kiniksa Pharmaceuticals International, plcCL A(KNSA)29,20029,2000$1.87M$2.18M0.44%+$311.3K
Corcept Therapeutics Incorporated(CORT)018,000+18,000$0$2.07M0.42%+$2.07M
Bright Minds Biosciences Inc38,40738,4070$2.70M$1.91M0.39%-$782.7K
Eyepoint Inc767,098464,698-302,400$10.97M$1.52M0.31%-$9.45M
Recursion Pharmaceuticals, Inc.CL A(RXRX)0334,402+334,402$0$1.38M0.28%+$1.38M
Agilent Technologies, Inc.(A)05,800+5,800$0$999.4K0.20%+$999.4K
Prokidney CorpCL A1,806,939553,744-1,253,195$3.69M$919.2K0.19%-$2.77M
Praxis Precision Medicines, Inc.(PRAX)2,5002,5000$837.0K$728.1K0.15%-$108.9K
Pepgen Inc205,324205,3240$369.6K$496.9K0.10%+$127.3K
MBX Biosciences, Inc.(MBX)08,300+8,300$0$486.5K0.10%+$486.5K
Spyre Therapeutics, Inc.(SYRE)4,0004,0000$355.1K$356.1K0.07%+$1.0K
Ginkgo Bioworks Holdings IncCL A020,444+20,444$0$262.3K0.05%+$262.3K
Climb Bio Inc021,097+21,097$0$242.0K0.05%+$242.0K
Alumis Inc278,5460-278,546$7.84M$0—-$7.84M
Compass Therapeutics, Inc.(CMPX)383,2000-383,200$839.2K$0—-$839.2K
Ionis Pharmaceuticals, Inc.(IONS)144,3760-144,376$11.45M$0—-$11.45M
Kodiak Sciences Inc.(KOD)17,0190-17,019$663.1K$0—-$663.1K
Nuvalent Inc4,9000-4,900$605.1K$0—-$605.1K
Palisade Bio, Inc.(PALI)1,992,3670-1,992,367$4.16M$0—-$4.16M
Sionna Therapeutics, Inc.(SION)119,7410-119,741$5.27M$0—-$5.27M
Tenax Therapeutics, Inc.(TENX)42,0800-42,080$612.3K$0—-$612.3K
Xenon Pharmaceuticals Inc.(XENE)65,0000-65,000$3.92M$0—-$3.92M
Page 1 of 1
Artia Global Partners LP — 13F Holdings — Q3 2026 | TickerTrail